Suppr超能文献

比较个性化医疗的不同科学方法:研究伦理与隐私保护。

Comparing different scientific approaches to personalized medicine: research ethics and privacy protection.

作者信息

Langanke Martin, Brothers Kyle B, Erdmann Pia, Weinert Jakob, Krafczyk-Korth Janina, Dörr Marcus, Hoffmann Wolfgang, Kroemer Heyo K, Assel Heinrich

机构信息

Faculty of Theology, University of Greifswald, Greifswald, Germany.

出版信息

Per Med. 2011 Jul;8(4):437-444. doi: 10.2217/pme.11.34.

Abstract

In this article, two different scientific approaches to personalized medicine are compared. Biorepository at Vanderbilt University (BioVU) is a genomic biorepository at Vanderbilt University Medical Center in Nashville, TN, USA. Genetic biosamples are collected from leftover clinical blood samples; medical information is derived from an electronic medical records. Greifswald Approach to Individualized Medicine is a research resource at the University of Greifswald, Germany, comprised of clinical records combined with biosamples collected for research. We demonstrate that although both approaches are based on the collection of clinical data and biosamples, different legal milieus present in the USA and Germany as well as slight differences in scientific goals have led to different 'ethical designs'. While BioVU can successfully operate with an 'opt-out' mechanism, an informed consent-based 'opt-in' model is indispensable to allow GANI_MED to reach its scientific goals.

摘要

在本文中,对个性化医疗的两种不同科学方法进行了比较。范德堡大学生物样本库(BioVU)是美国田纳西州纳什维尔范德堡大学医学中心的一个基因组生物样本库。基因生物样本取自剩余的临床血液样本;医学信息则来自电子病历。格赖夫斯瓦尔德个性化医疗方法是德国格赖夫斯瓦尔德大学的一项研究资源,由临床记录与为研究收集的生物样本组成。我们证明,尽管这两种方法都基于临床数据和生物样本的收集,但美国和德国不同的法律环境以及科学目标上的细微差异导致了不同的“伦理设计”。虽然BioVU可以通过“退出”机制成功运作,但基于知情同意的“加入”模式对于让格赖夫斯瓦尔德大学个性化医疗项目(GANI_MED)实现其科学目标来说是必不可少的。

相似文献

2
Cohort profile: Greifswald approach to individualized medicine (GANI_MED).
J Transl Med. 2014 May 23;12:144. doi: 10.1186/1479-5876-12-144.
3
Patient awareness and approval for an opt-out genomic biorepository.
Per Med. 2013 Jun;10(4). doi: 10.2217/pme.13.34.
4
Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVU.
Clin Pharmacol Ther. 2013 Feb;93(2):204-11. doi: 10.1038/clpt.2012.230. Epub 2012 Nov 21.
5
Two large-scale surveys on community attitudes toward an opt-out biobank.
Am J Med Genet A. 2011 Dec;155A(12):2982-90. doi: 10.1002/ajmg.a.34304. Epub 2011 Nov 7.
7
Phenotype-Driven Plasma Biobanking Strategies and Methods.
J Pers Med. 2015 May 14;5(2):140-52. doi: 10.3390/jpm5020140.
8
Ethical and practical challenges to studying patients who opt out of large-scale biorepository research.
J Am Med Inform Assoc. 2013 Dec;20(e2):e221-5. doi: 10.1136/amiajnl-2013-001937. Epub 2013 Jul 25.
10
[The origin of informed consent].
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.

引用本文的文献

1
Innovations in Health Care-A Conceptual Framework.
Int J Environ Res Public Health. 2021 Sep 24;18(19):10026. doi: 10.3390/ijerph181910026.
2
Applying systems biology to biomedical research and health care: a précising definition of systems medicine.
BMC Health Serv Res. 2017 Nov 21;17(1):761. doi: 10.1186/s12913-017-2688-z.
4
Cohort profile: Greifswald approach to individualized medicine (GANI_MED).
J Transl Med. 2014 May 23;12:144. doi: 10.1186/1479-5876-12-144.
5
Secondary use of clinical data: the Vanderbilt approach.
J Biomed Inform. 2014 Dec;52:28-35. doi: 10.1016/j.jbi.2014.02.003. Epub 2014 Feb 14.
6
Implications of the incidentalome for clinical pharmacogenomics.
Pharmacogenomics. 2013 Aug;14(11):1353-62. doi: 10.2217/pgs.13.119.
7
Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study.
Eur Radiol. 2013 May;23(5):1343-51. doi: 10.1007/s00330-012-2723-8. Epub 2012 Dec 13.

本文引用的文献

2
"Human non-subjects research": privacy and compliance.
Am J Bioeth. 2010 Sep;10(9):15-7. doi: 10.1080/15265161.2010.492891.
3
Principles of human subjects protections applied in an opt-out, de-identified biobank.
Clin Transl Sci. 2010 Feb;3(1):42-8. doi: 10.1111/j.1752-8062.2010.00175.x.
4
Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record.
Am J Hum Genet. 2010 Apr 9;86(4):560-72. doi: 10.1016/j.ajhg.2010.03.003. Epub 2010 Apr 1.
5
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.
Bioinformatics. 2010 May 1;26(9):1205-10. doi: 10.1093/bioinformatics/btq126. Epub 2010 Mar 24.
6
Managing incidental findings in human subjects research: analysis and recommendations.
J Law Med Ethics. 2008 Summer;36(2):219-48, 211. doi: 10.1111/j.1748-720X.2008.00266.x.
7
Development of a large-scale de-identified DNA biobank to enable personalized medicine.
Clin Pharmacol Ther. 2008 Sep;84(3):362-9. doi: 10.1038/clpt.2008.89. Epub 2008 May 21.
8
Attitudes and perceptions of patients towards methods of establishing a DNA biobank.
Cell Tissue Bank. 2008 Mar;9(1):55-65. doi: 10.1007/s10561-007-9051-2. Epub 2007 Oct 25.
10
Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think?
Eur J Public Health. 2006 Aug;16(4):433-40. doi: 10.1093/eurpub/cki198. Epub 2005 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验